|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Total revenue | |||||
| Cost of revenue | |||||
| Total cost of revenue | |||||
| Gross loss | |||||
| Research and development expenses | |||||
| General and administrative expenses | |||||
| Selling and marketing expenses | |||||
| Litigation settlement, net | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Interest income | |||||
| Fair value at issuance of Series A warrants | |||||
| Change in fair value of warrant liabilities | |||||
| Fair value gain on settlement of share subscription liability | |||||
| Other income (expense), net | |||||
| Net loss before income taxes | |||||
| Income tax provision | |||||
| Net loss | |||||
| Unrealized (loss) gain on available-for-sale securities | |||||
| Total comprehensive loss | |||||
| Net loss per share, basic | |||||
| Net loss per share, diluted | |||||
| Weighted-average shares used in computing net loss per share, basic | |||||
| Weighted-average shares used in computing net loss per share, diluted | |||||
Loading...